Drug developers are getting closer to tapping an unmined gold reserve of protein–protein interaction targets.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Mullard, A. Protein–protein interaction inhibitors get into the groove. Nat Rev Drug Discov 11, 173–175 (2012). https://doi.org/10.1038/nrd3680
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3680
- Springer Nature Limited
This article is cited by
-
Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α
Scientific Reports (2023)
-
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
Nature Communications (2023)
-
Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein–protein interaction-oriented library and machine learning
Scientific Reports (2021)
-
The CASP13-CAPRI targets as case studies to illustrate a novel scoring pipeline integrating CONSRANK with clustering and interface analyses
BMC Bioinformatics (2020)
-
Photoregulated macrocyclic cell-penetrating peptides (microreview)
Chemistry of Heterocyclic Compounds (2020)